|
Volumn 161, Issue 7, 2014, Pages 531-532
|
In response
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
FLUOROBENZENE;
HEPTANOIC ACID DERIVATIVE;
PYRIMIDINE DERIVATIVE;
PYRROLE DERIVATIVE;
SULFONAMIDE;
CIRCADIAN RHYTHM;
DISEASE ASSOCIATION;
DRUG RECHALLENGE;
DRUG SAFETY;
HUMAN;
LETTER;
MYALGIA;
NONPARAMETRIC TEST;
PAIN ASSESSMENT;
PRACTICE GUIDELINE;
RECALL BIAS;
SINGLE PATIENT TRIAL;
STUDY DESIGN;
TREATMENT DURATION;
VISUAL ANALOG SCALE;
WIRELESS COMMUNICATION;
CHEMICALLY INDUCED;
FEMALE;
HYPERCHOLESTEROLEMIA;
MALE;
FEMALE;
FLUOROBENZENES;
HEPTANOIC ACIDS;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERCHOLESTEROLEMIA;
MALE;
MYALGIA;
PYRIMIDINES;
PYRROLES;
SULFONAMIDES;
|
EID: 84908105589
PISSN: 00034819
EISSN: 15393704
Source Type: Journal
DOI: 10.7326/l14-5019-2 Document Type: Letter |
Times cited : (14)
|
References (4)
|